Multilingualism as a factor of resilience to Alzheimer's disease and related dementias in India
多语言使用是印度阿尔茨海默病和相关痴呆症恢复能力的一个因素
基本信息
- 批准号:10584373
- 负责人:
- 金额:$ 81.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-15 至 2027-11-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAge YearsAgingAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAmyloidAttentionBiologicalBiological MarkersBloodBlood TestsBlood specimenBrain regionBuffersCognitionCognitiveCognitive agingCommunitiesCountryDataDementiaDiagnosticEducationElderlyEnvironmental Risk FactorFamilyFrequenciesFundingGeographic LocationsHealthHealthcareImpaired cognitionIncomeIndiaIndividualInterventionInterviewInvestigationLanguageLanguage DevelopmentLife Cycle StagesLinguisticsMagnetic Resonance ImagingMeasuresMemoryMethodologyMultilingualismOutcomeParticipantPathologyPathway interactionsPersonal SatisfactionPersonsPlasmaPopulationPopulation HeterogeneityPreventionPublic HealthRecording of previous eventsReportingResearchRiskRisk FactorsRoleSamplingScheduleSchoolsSocial ClassSocioeconomic StatusStandardizationSubgroupTestingThickVariantVenousWorkbilingualismbrain healthbrain volumecerebral atrophycognitive functioncognitive reservecognitive testingdementia riskethnic diversityexecutive functionexperiencehealth determinantsinsightliteracylow and middle-income countriesmachine learning methodmodifiable riskmortalityneuroimagingneuroimaging markerneuropathologypromote resilienceprotective effectresilienceresilience factorresponserural residencesocialsocial culturesociocultural determinantsociodemographicssocioeconomicstau Proteinswhite matter
项目摘要
Project Summary/Abstract
By 2050, two-thirds of older individuals with dementia will live in low-and middle-income countries (LMICs). As
LMICs continue to experience a reduction in mortality, it is critical to determine factors that confer protection and
resilience toward Alzheimer’s disease and related dementias (ADRD). Some studies find that bilinguals are at
reduced ADRD risk compared to monolinguals, but other studies do not find evidence of a bilingual advantage.
The rationale for this study is that the equivocal findings of prior research has been driven largely by
methodological inconsistencies that limit our understanding of bilingualism’s role in cognitive aging such as: 1)
inadequate control for potential confounders that limit our ability to infer whether bilingualism has a direct effect
on cognition or whether these relationships are due to environmental and sociocultural factors, 2) limited
inclusion of markers of neuropathology, and 3) little attention given to within-group differences among bilinguals,
such as age of second language (L2) acquisition, proficiency, frequency of language use, number of languages
spoken, and diversity of language families. India offers a unique opportunity to study the role of bilingualism in
cognitive reserve and resilience, given its rich linguistic and sociocultural diversity across the country. The overall
aim of the study is to leverage the unique features of India’s linguistic and sociodemographic landscape to
discern whether bilingualism modifies the association between blood-based and neuroimaging biomarkers of
ADRD and cognition and cognitive decline. This study will analyze available plasma-based measures of amyloid
and tau pathologies, MRI, and cognitive assessments from the Longitudinal Aging Study in India–Diagnostic
Assessment of Dementia (LASI-DAD), a large, population-representative study of ageing and dementia in India.
Specifically, the project will 1) determine whether bilingualism modifies the association between ADRD
biomarkers (blood-based or neuroimaging) and cognitive outcomes, 2) evaluate whether the protective effect of
bilingualism differs across diverse life-course environmental determinants of health, and 3) deconstruct language
use within bilinguals in India to understand the mechanisms by which bilingualism confers cognitive reserve
against biological risk of ADRD. We hypothesize that bilingualism will buffer the effects of blood AD-biomarkers
(amyloid, and tau plasma levels), cortical atrophy, and white matter integrity on baseline cognition and rate of
cognitive decline compared to monolinguals in the domains of memory, language, and executive functioning. In
addition, by deconstructing bilingualism, we hypothesize that earlier age of L2 acquisition, higher bilingual
proficiency, greater daily multiple language use, higher number of languages acquired, and greater distance
between language families will confer cognitive reserve, independent of confounding sociocultural factors (i.e.,
education, socioeconomic status). This proposal will enhance the field of ADRD by uncovering the underlying
mechanisms of resilience to ADRD that may be modifiable and transferable to other populations.
项目概要/摘要
到 2050 年,三分之二的痴呆症老年人将生活在低收入和中等收入国家 (LMIC)。
中低收入国家的死亡率持续下降,因此确定提供保护和保护的因素至关重要
一些研究发现,双语者对阿尔茨海默病和相关痴呆症(ADRD)的恢复能力处于最高水平。
与单语者相比,ADRD 风险降低,但其他研究并未发现双语优势的证据。
这项研究的基本原理是,先前研究的模棱两可的结果很大程度上是由
方法上的不一致限制了我们对双语在认知老化中的作用的理解,例如:1)
对潜在混杂因素的控制不足,限制了我们推断双语是否有直接影响的能力
认知或这些关系是否归因于环境和社会文化因素,2)有限
纳入神经病理学标记,3)很少关注双语者之间的组内差异,
例如第二语言 (L2) 习得年龄、熟练程度、语言使用频率、语言数量
印度的口语和语系多样性为研究双语的作用提供了独特的机会。
鉴于全国丰富的语言和社会文化多样性,认知储备和复原力。
该研究的目的是利用印度语言和社会人口景观的独特特征
辨别双语是否会改变血液生物标志物和神经影像生物标志物之间的关联
ADRD 与认知和认知能力下降 本研究将分析现有的基于血浆的淀粉样蛋白测量方法。
印度纵向衰老研究中的 tau 蛋白病理学、MRI 和认知评估——诊断
痴呆症评估 (LASI-DAD),一项针对印度老龄化和痴呆症的大型人口代表性研究。
具体来说,该项目将 1) 确定双语是否会改变 ADRD 之间的关联
生物标志物(基于血液或神经影像)和认知结果,2)评估是否具有保护作用
双语在健康的不同生命过程环境决定因素中有所不同,并且 3) 解构语言
在印度的双语者中使用它来了解双语赋予认知储备的机制
我们发现双语可以缓冲血液 AD 生物标志物的影响。
(淀粉样蛋白和 tau 血浆水平)、皮质萎缩和白质完整性对基线认知和认知率的影响
与单语者相比,他们在记忆、语言和执行功能方面的认知能力下降。
此外,通过解构双语,我们追求二语习得年龄越早、双语能力越高。
熟练程度、日常多语言使用量更大、获得的语言数量更多、距离更远
语言家族之间的差异将赋予认知储备,独立于混杂的社会文化因素(即,
该提案将通过揭示潜在的问题来增强 ADRD 领域。
ADRD 的恢复机制可以修改并转移到其他人群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leon Aksman其他文献
Leon Aksman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
停止使用羟氯喹治疗老年狼疮病 (SHIELD)
- 批准号:
10594743 - 财政年份:2023
- 资助金额:
$ 81.74万 - 项目类别:
Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)
芝加哥不同高危女性人群乳腺癌替代预防研究 (CAPSBRACA)
- 批准号:
10737279 - 财政年份:2023
- 资助金额:
$ 81.74万 - 项目类别:
Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami
预测撒哈拉以南非洲艾滋病毒流行率的年龄变化:应对银色海啸的必要流行病学步骤
- 批准号:
10762075 - 财政年份:2023
- 资助金额:
$ 81.74万 - 项目类别:
Feasibility of a Hearing Program in Primary Care for Underserved Older Adults
为服务不足的老年人提供初级保健听力计划的可行性
- 批准号:
10727976 - 财政年份:2023
- 资助金额:
$ 81.74万 - 项目类别:
Assessing the Impact of Age, Sex, and Menopause on Scleral Biomechanics and Gene Expression
评估年龄、性别和更年期对巩膜生物力学和基因表达的影响
- 批准号:
10726826 - 财政年份:2023
- 资助金额:
$ 81.74万 - 项目类别: